News
Email Page
Chad Landmon Presented on Bioequivalence in Boston
September 28, 2010

On September 28, 2010, the American Conference Institute hosted its FDA Boot Camp in Boston. Chad Landmon, Chair of the FDA Practice Group at Axinn, gave a presentation focusing on bioequivalence issues and their impact on FDA approval of generic products. A copy of Chad's presentation can be viewed here:

Additional Documents:

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.